MeRes100
MeRes100 - BRS Sirolimus Eluting BioResorbable Vascular Scaffold System
100 μm strut thickness, PLLA scaffold with PDLLA drug coating, platinum markers
Coronary StentsMeril Life Sciences
Next generation bioresorbable scaffold with enhanced radiopacity, featuring 100 µm strut thickness for optimal vessel healing and drug elution with sirolimus coating for restenosis prevention
Product overview
Next generation bioresorbable scaffold with enhanced radiopacity, featuring 100 µm strut thickness for optimal vessel healing and drug elution with sirolimus coating for restenosis prevention
Technical specifications
| scaffold material | BioResorbable PLLA (Poly L-lactide) |
| strut thickness | 100 µm |
| drug | Sirolimus |
| drug dose | 1.25 µg/mm² |
| polymer | BioResorbable PDLLA (Poly D, L-lactide) |
| ro markers | Platinum tri-axial markers |
| delivery system | Rapid Exchange |
| nominal pressure | 9 atm |
| rated burst pressure | 16 atm |
| balloon overhang | < 0.5 mm |
| shaft diameter | Proximal 1.95 F / Distal 2.7 F |
| catheter length | 140 cm |
| guide catheter compatibility | 6 F (Min. I.D 0.070" / 1.8 mm) |
| max guidewire | 0.014" (0.36 mm) |
| crossing profile | 1.2 mm average for 3.00 mm diameter |
Clinical scope
Procedures
- • Percutaneous Coronary Intervention
- • Coronary Angioplasty
Anatomical focus
- • Coronary Arteries
Indications & use cases
coronary revascularizationrestenosis preventiondrug-eluting bioresorbable scaffoldtemporary vessel supportvessel healing restoration